Evidence map›Paper›PMID 42808050›Full record

ArticleNature reviews. Materials2026

Engineering complexity into protein-based biomaterials for biomedical applications.

Nicole E Gregorio, Cyrus M Haas, Neil P King, Cole A DeForest

Abstract read
In one paragraph

Article in Nature reviews. Materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicole E GregorioDepartment of Bioengineering, University of Washington, Seattle, WA, USA.ORCID 0000-0002-7287-209X
Cyrus M HaasDepartment of Chemical Engineering, University of Washington, Seattle, WA, USA.ORCID 0000-0002-2204-9847
Neil P KingInstitute for Protein Design, University of Washington, Seattle, WA, USA.
Cole A DeForestDepartment of Bioengineering, University of Washington, Seattle, WA, USA.ORCID 0000-0003-0337-3577

Funding

Project 5: mRNA and mRNA-launched nanoparticle vaccinesU19AI181881 · NIAID · UNIVERSITY OF WASHINGTON · PI BLOOM, JESSE D · 2024 to 2024
$41.1M
Structure-based design of broadly protective coronavirus vaccinesP01AI167966 · NIAID · UNIVERSITY OF WASHINGTON · PI Neil King, David Veesler · 2022 to 2026
$15.3M
Mimicking, Exploiting, and Understanding Biology's Heterogeneity in 4DR35GM138036 · NIGMS · UNIVERSITY OF WASHINGTON · PI Cole A DeForest · 2020 to 2026
$2.3M
NIAID NIH HHS P01 AI167966NIAID NIH HHS U19 AI181881NIGMS NIH HHS R35 GM138036
6 · The paper itself

Abstract

Protein-based biomaterials are growing in popularity for biomedical applications, in part owing to their innate ability to interface with biological systems. These materials, in the form of fibres, nanoparticles and hydrogels, have shown promise as drug delivery vehicles, tissue scaffolds and vaccines. Moreover, the explosion of protein engineering tools and the inception of de novo protein design have transformed our ability to explore new protein structures, enabling the creation of novel materials with diverse properties and furthering their customization for various applications. In this Perspective, we explore the coming of age of protein engineering technologies and their impact on biomaterials. Starting with naturally sourced materials, we highlight common protein building blocks and fabrication methods, as well as recent applications of each. We subsequently explore rationally designed materials and conclude by discussing the potential impacts that de novo design will have on the biomaterials field.

Identifiers

PMID42808050
PMCPMC13618721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.